Existing-home sales in the U.S. dropped 5.5% month-over-month and 8.8% year-over-year in October, reaching the lowest level since August 2010. The decline is attributed to mortgage rates rising to their highest since 2000, making home buying more difficult. Despite fewer sales, homeowners remain financially stable with low distressed sales. If mortgage rates decrease, there could be significant pent-up demand given steady job growth.
Existing-home sales in the U.S. fell 5.5% in October, marking the lowest level since August 2010 amid high mortgage rates. For readers following the Real Estate sector, here is Pluang's market snapshot as of Nov 12, 2026 20:21 WIB: out of 47 priced US Real Estate stocks, 21 rose and 24 fell. Notable movers include Opendoor Technologies Inc at USD 1.31 with a 4.03% decline and a typical hold time of 34 days, CareTrust REIT Inc. at USD 37.52 down 2.82%, and American Homes 4 Rent Class A at USD 33.03 up 1.54% with a typical hold time of 83 days.
The global specialty zeolites market, valued at $1 million in 2025, is projected to reach $1.5 million by 2032 with a 5.8% CAGR. Growth is fueled by stricter environmental regulations and rising demand in water treatment, petrochemicals, agriculture,...
The global cell lysis and cell fractionation market, valued at $2.8 billion in 2025, is projected to grow to $4.5 billion by 2032 at a 7% CAGR. Growth is fueled by advances in biotechnology, increased life sciences research investments, and rising de...
atQor has been named a finalist for the 2026 Microsoft Partner of the Year Award in the Agents category, recognized for its innovative and scalable agentic AI solutions deployed across nine industries. The company developed 252 AI agents in FY26, wit...
Interlink Electronics announced a 3.4% revenue increase to $3.06 million for Q3 2026 and a 9.6% rise to $9.9 million for the first nine months of 2026, driven by higher shipments of force-sensing and gas-sensor products. The company reported a net lo...
ALS Canada, with renewed funding from TD Bank, is advancing its national strategy for ALS genetics to enhance access to genetic information, counselling, and care for Canadians affected by or at risk of ALS. This builds on the 2024 pilot of the first...
